Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial Cancer

Stopped early · Phase 3

Conditions studied: Endometrial Cancer

In brief

RATIONALE: Estrogen replacement therapy may improve quality-of-life in postmenopausal women with endometrial cancer. It is not yet known whether estrogen replacement therapy will affect cancer recurrence. PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of estrogen replacement therapy in treating women who have stage I or stage II endometrial cancer.

Key facts

Study ID
NCT00002976
Run by
Gynecologic Oncology Group
People needed
2108
Starts
1997-06-01
Last updated by the study team
2013-04-11

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.